Genetic anomalies resulting in reproductive disorders;Anomalies genetiques entrainant des troubles de la reproduction

References en Gynecologie Obstetrique

Volumn 4, Issue 4, 1996, Pages 317-338

  Bouvattier, Cl ^a   Christin Maitre, S ^b   Bouchard, Ph ^b   Fauser, Bart C J M ^c  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Amenorrhea; Gonadotropins; Infertility; Reproduction; Sex steroids

Indexed keywords

GONADOTROPIN; SEX HORMONE;

AMENORRHEA; ENVIRONMENTAL FACTOR; FEMALE INFERTILITY; GENETIC DISORDER; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; REPRODUCTION; REVIEW; SEX CHROMOSOME;

EID: 0030389911     PISSN: 12448168     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (194)

1. Feichtinger W. 1991 Environmental factors and fertility Hum Reprod, 6: 1170-1175
2. Negro-Vilar A. 1993 Stress and environmental factors affecting fertility in men and women: overview. Environ Health Perspect, 101 (suppl 2): 59-64
3. Vermeulen A. 1993. Environment, human reproduction, menopause and andropause. Environ Health Perspect, 101 (suppl 2) 91-100
4. Singh R.P., Carr D.H. 1966 The anatomy and histology of XO human embryos and fetuses Anat Rec 155, 369
5. Ogata T., Matsuo N. 1995 Turner syndrome and female sex chromosome aberrations: deduction of the principal factor involved in the development of clinical features. Hum Genet 95, 607
6. Krauss C.M., Turksoy R.N., Atkins L., Laughlin C., Brown L.G., Page D.C. 1987 : Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 317, 125
7. Yen S.S.C., Jaffe R.B. 1991. in Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management Disorders of Sexual Development. W.B Saunders Company p 490-493
8. Fryns J.P. 1986. The female and the fragile X. Am J Med Genet, 23. 157-169
9. Schwartz C.E., Dean J., Howard-Peebles P.N. et al. 1994 Obstetrical and gynecological complications in fragile X carriers. Am J Med Genet, 51: 400-402
10. Turner G., Robinson H., Wake S. et al. 1994. Dizygous twinnings and premature menopause in fragile X syndrome. Lancet, 344, 1500
11. Tiepolo L., Zuffardi O. 1976 Localization of factors controlling spermatogenesis in the non-fluorescent portion of the human Y chromosome long arm. Hum Genet, 34. 119-124
12. Reijo R., Lee T.-Y., Sato P. et al. 1995. Diverse spermatogenic defects in humans caused by Y-chromosome deletions encompassing a novel RNA-binding protein gene Nature Genet , 10: 383-393
13. Najmabadi H, Huang V., Yen P., Subbarao M.N., Bhasin D. et al. 1996 Substantial prevalence of microdeletions of the Y-chromosome in infertile men with idiopathic azoospermia and oligozoospermia detected using a sequence-tagged site-based mapping strategy J Clin Endocrinol Metab 81. 1347-1352
14. Reijo R., Alagappan R.K., Patrizio P., Page D.C. 1996 Severe oligoospermia resulting from deletions of azoospermia factor gene on Y chromosome. Lancet ; 347: 1290-1293
15. Lutz B., Rugarli E.I., Eichele G. et al. 1993 X linked Kallmann syndrome. A neuronal targeting defect in the olfactory system? FEBS Lett, 325. 128-134
16. Schwanzel-Fukuda M., Bick D., Pfaff D.W. 1989. LHRH expressing cells do not migrate in an inherited hypogonadal (Kallmann) syndrome. Mol Brain Res, 6 311-326
17. Truwit C.L., Barkovich A.J., Grumbach M. et al. 1993. MR imaging of Kallmann's syndrome, a genetic disorder of neuronal migration affecting the olfactory and genital system Am J Neuroradiol, 14: 827-838
18. Goldenberg R.L., Powell R.D., Rosen S.L. et al. 1976 Ovarian morphology in women with anosmia and hypogonadotropic hypogonadism Am J Obstet Gynecol, 126: 91-94
19. France B., Guioli S., Pragliola A. et al. 1991. A gene deleted in Kallmann's syndrome shares, homology with neural cell adhesion and oxonal path-tinding molecules. Nature, 353 529-536
20. Legouis R , Hardelin J.P., Levilliers J. et al. 1991 The candidate gene for the X linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell, 67 423-435
21. Bick D., Franco B., Sherins R.J. et al 1992 Brief report intragenic deletion of the KALIG-1 gene in Kallmann's syndrome N Engl J Med, 326: 1752-1755
22. Hardelin J.P., Levilliers J., Young J. et al. 1993 Xp223 deletions in isolated familial Kallmann's syndrome. J Clin Endocrinol Metab, 76: 827-831
23. Prager O., Braunstein G.D. 1993 X chromosome linked Kallmann's syndrome pathology at the molecular level J Clin Endocrinol Metab, 76 824-826
24. Waldstreicher J., Seminara S.B., Jameson J.I., Geyer A., Nachtigall L.B., Boepple P.A., Holmes L B., Crowley W.F. 1996. Jr The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human J. Clin Endocrinol Metab, 81: 4388-4395
25. Masson A.J., Hayflick J.S., Zoeller R.T. et al. 1986 A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science, 234. 1366 1371
26. Masson A.J., Pitts S.L., Nikolics K. et al. 1986 The hypogonadal mouse, reproductive functions restored by gene therapy Science, 234 1372-1378
27. Weiss J., Crowley W.F., Jameson L. 1989. Normal structure of the GnRH gene in patients with GnRH deficiency and idiopathic hypogonadotrophic hypogonadism J Clin Endocrinol Metab, 69: 299-303
28. Weiss J., Adams E., Whitcomb R.W. et al. 1991 Normal sequence of the gonadotropin releasing hormone gene in patients with idiopathic hypogonadotrophic hypogonadism. Biol Reprod, 45: 743-747
29. Rosenfield R.L. 1991 Puberty and its disorders in girls Endocrinol Metab Clin North Am, 20: 15-42
30. Nakayama Y., Wondisford F.E., Lash R.W. et al. 1990 Analysis of the gonadotropin releasing hormone gene structure in families with central precocious puberty and idiopathic hypogonadotrophic hypogonadism. J Clin Endocrinol Metab, 70 1233-1238
31. Habiby R.L., Bœpple P., Nachtigall L. et al. 1996. Adrenal hypoplasia congenita with hypogonadotropic by pogonadism. J Clin Invest, 98 1055-1062
32. Guo W., Burris T.P., Zhang Y.-H. et al. 1996. Genomic sequence of the DAX-1 gene an orphan nuclear receptor responsible for X-linked adrenal hypoplasia congenita and hspogonadotropic hypogonadism. J Clin Endocrinol Metab, 81 2481-2486
33. Burris T.P., Guo W., Mc Cabe ERB. 1996. The gene responsible for adrenal hypoplasia congenita. DAX-1 encodes a nuclear hormone receptor that defines a new class within the superfamily Rec Prog Horm Res, 51 241-260
34. Swain A., Zanaria E., Hacker A. et al. 1996 Mouse DAX-1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function Nature Genet, 12: 404-409
35. Pierce J.G., Parson T.F. 1981 Glycoprotein hormones: structure and function Annu Rev Biochem, 50 465-476
36. Gharib S.D., Wierman M.E., Shupnik M.A. et al. 1990. Molecular biology of the pituitary gonadotropins Endocr Rev, 11 177-199
37. Weiss J., Axelrod L., Whitcomb R.W. et al. 1992. Hypogonadism caused by a single amino-acid substitution in the β subunit of LH N Engl J Med, 326 179-183
38. Axelrod L., Neer R.M., Kliman B. 1979 Hypogonadism in a male with immunologically active, biologically inactive luteinizing hormone: an exception to a venerable rule J Clin Endocrinol Metab, 48 279-287
39. Beitins I.Z., Axelrod L., Ostrea T. et al. 1981 Hypogonadism in a male with an immunologically active, biologically inactive luteinizing hormone characterization of the abnormal hormone J Clin Endocrinol Metab, 52: 1143-1149
40. Dacou-Voutetatkis C., Felquate D.M., Drakopoulou M. et al. 1990 Familial hypothyroidism caused by a nonsense mutation in the TSH α subunit gene Am J Hum Genet, 46: 988-993
41. Petersson K., Ding Y.Q., Huhtaniemi I. 1992. An immunologically anomalous LH variant in a healthy woman J Clin Endocrinol Metab, 74: 164-171
42. Petersson K., Mäkelä M.M., Dahlen P., Lamminen et al. Gene polymorphism found in the LHb (gene of an immunologically anomalous variant of human luteinizing hormone. Eur J Endocrinol 130 (Suppl 2) 65
43. Furui K., Suganuma N., Tsukahara S.I. et al. 1994. Identification of two point mutations in the gene coding for LHβ subunit, associated with immunologically anomalous LH variants. J Clin Eridocrinol Metab, 78: 107-113
44. Rabinowitz D., Benveniste R., Lindler J. et al. 1979. Isolated FSH deficiency revisited. N Engl J Med, 300: 126-128
45. Mattews C.H., Borgato S., Beck-Peccoz P. et al. 1993 Primary amenorrhoea and infertility due to a mutation in the β subunit of the follicle stimulating hormone. Nat Genet, 5: 83-86
46. Ohzeki T., Motozumi H., Hanaki K. et al. 1993 Carbohydrate-deficient glycoprotein syndrome in a girl with hypogonadism due to inactive follicle stimulating hormone. Horm Metab Res, 25: 646-648
47. Layman L.C., Wilson J.T., Huey L.O. et al. 1992. Gonadotropin releasing hormone, follicle stimulating hormone β, luteinizing hormone β gene structure in idiopathic hypogonadotropic hypogonadism. Fertil Steril, 57: 42-49
48. Layman L.C., Shelley M.E., Huey L.O. et al. 1993 Follicle stimulating hormone β gene structure in premature ovarian failure. Fertli Steril, 60: 852-857
49. Jia X.C., Oikawa M., Bo M. et al. 1991 Expression of human luteinizing hormone (LH) receptor interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species. Mol Endocrinol, 5: 759-768
50. Tilly J.L., Aihara T., Nishimori K. et al. 1992. Expression of recombinant human follicle stimulating hormone receptor species specific ligand binding, signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts. Endocrinology, 131: 799-806
51. Combarnous Y. 1992 Molecular basis of the specificity of binding of glycoprotein hormones to their receptors. Endocr Review, 13 670-691
52. Rousseau-Merck M.F., Atger M., Loosfelt H. et al. 1993. The chromosomal location of the human FSH receptor gene on 2p21-2p16 is similar to the LH receptor gene Genomics, 15: 222-224
53. Spiegel A.M., Gierschik P., Levine M.A. et al. 1985. Clinical implications of guanine nocleotide binding proteins as receptor effector couplers. N Engl J Med, 321: 26-33
54. Krasnow J. 1991. Advances in understanding ovarian physiology, regulation of steroidogenic enzymes in ovarian follicular differentiation Sem Reprod Endocrinol, 9: 283-302
55. Manasco P.K., Girton M.E., Diggs R.L. et al. 1991. A novel testis stimulating factor in familial male precocious puberty N Engl J Med, 324 227-231
56. Shenker A., Laue L., Kosugi S. et al. 1993. A constitutively activating mutation of the LH receptor in familial male precocious puberty Nature, 365: 652-654
57. Laue L., Hsueh A.J.W., Cutler G.B. et al. 1995. Genetic heterogeneity of activating mutation of the LH receptor in familial male precocious puberty Proc Natl Acad Sci USA
58. Kraaij R., Post M., Kremer H. et al. 1995. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male limited precocious puberty J Clin Endocrinol Metab, 80: 3168-3172
59. Rosenthal I.R, Refetoff S., Rich B. et al. 1996. Response to challenge with GnRH agonist in a mother and her two sons with a constitutively activating mutation of the Luteinizing Hormone receptor- A clinical Research Center Study. J. Clin Endocrinol Metab, 81: 3802-3806
60. Yano K., Hidaka A., Saji M. et al. 1994. A sporadic case of male limited precocious puberty has the same constitutively activating point mutation in LH/CG receptor as familial cases J Clin Endocrinol Metab, 79: 1818-1823
61. Kremer H., Mariman E., Otten B.J. et al. 1993. Cosegregation of missense mutations of the LH receptor gene with familial male limited precocious puberty Hum Mol Genet, 2: 1779-1783
62. Parma J., Duprez L., van Sande J. et al. 1993. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas Nature 1993, 355. 649-651
63. Dryja T.P., Mc Gee T.L., Hahn L.B. et al. 1990. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa N Engl J Med, 323: 1302-1307
64. Lefkowitz R.L. 1993. G protein coupled receptors turned on to ill effect Nature, 365. 603-604
65. Bobbins L.S., Nadeau J.H., Johnson K.R. et al. 1993. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell, 72: 827-834
66. Berthezéne F., Forest M.G., Grimaud J.A., Claustrat B., Mornex R. 1976 Leydig-cell agenesis a case of male pseudohermaphroditism. N Engl J Med; 295 969-972
67. Kremer H., Kraaij R., Toledo S.P.A. et al. 1995. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nature Genet, 9: 160-164
68. Laue L., Wu S.M., Kudo M. et al. 1995. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet, 4: 1429-1433
69. Latronico A.C., Anasti J., Arnhold I.J.P. et al. 1996 Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone receptor gene. N Engl J Med, 334: 507-512
70. Toledo S.P.A., Brunner H.G., Kraaij R., Post M., Dahia P.L.M. et al. 1996 An inactivating mutation of the Luteinizing Hormone receptor causes amenorrhea in a 46. XX female J Clin Endocrinol Metab, 81. 3850-3854
71. Laue LL, Wu S.M., Kudo M., Bourdony C.J., Cutler G.B. Jr, Hsueh A.J.W., Chan W.-Y. 1996. Compound heterozygous mutations of the Luteinizing hormone receptor gene in Leydig cell hypoplasia Mol Endocrinol; 10. 987-997
72. Gromoll J., Simoni M., Nieschlag E. 1996. An activating mutation of the follicle stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man J Clin Endocrinol Metab, 81 1367-1370
73. Aittomäki K., Lucena J.L.D., Pakarinen P. et al. 1995. Mutation in the follicle stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure Cell, 82 959-968
74. Aittomäki K., Herva R., Stenman U.-H. et al. 1996. Clinical features of primary ovarian failure caused by a point mutation in the Follicle-Stimulating Hormone receptor zone J Clin Endocrinol Metab 81 3722-3726
75. Conti M., Jin C., Monaco L. et al. 1991. Hormone regulation of cyclic nucleotide phosphodiesterases Endocr Rev, 12: 218-234
76. Foster C.M., Ross J.L., Shawker T. et al. 1984. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. J Clin Endocrinol Metab, 58: 1161-1165
77. Wierman M.E., Beardsworth D.E., Mansfield M.J. et al. 1985. Puberty without gonadotropins A unique mechanism of sexual development. N Engl J Med, 321: 65-72
78. Weinstein L.S., Shenker A., Gejman P.V. 1991. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med, 325: 1688-1695
79. Levine M.A., Downs R.W., Moses A.M. et al. 1983 Resistance to multiple hormones in patients with pseudohypoparathyroidism Am J Med, 74: 545-556
80. Patten J.L., Johns D.R., Valle D. et al. 1990. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med, 322: 1412-1419
81. Weinstein L.S., Gejman P.V., Frieman E. et al. 1990 Mutations of the Gs α subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA, 87: 8287-8290
82. Miric A., Vechio J.D., Levine M.A. 1993. Heterogeneous mutations in the gene encoding the a subunit of the stimulatory G protein of adenylyl cyclase in the Albright heredetary osteodystrophy. J Clin Endocrinol Metab, 76: 1560-1568
83. Iiri T., Herzmark P., Nakamoto J.M., van Dop C., Bourne H.R. 1994 Rapid GDP release from Gs α in patients with gain and loss of endocrine function Nature, 371: 109-110
84. Bradshaw K.D., Waterman M.R., Couch R.T. et al. 1987. Characterization of complementary deoxyribonucleic acid for human adrenocortical 17 α hydroxylase. Mol Edocrinol; 1: 348-354
85. Grumbach M.M. and Conte F.A. 1992. Disorders of sex differenciation In Wilson J.D and Foster D.W. (eds), Williams, texbook of Endocrinology. Saunders, Philadelphia p 853-951
86. Hauffa B.P., Miller W.L., Grumbach M.M. et al.1985. Congenital adrenal hyperplasia due to deficient cholesterol-side-chain cleavage activity (20-22 desmolase) in a patient treated for 18 years Clin Endocrinol; 23. 481-493
87. Miller W.L. and Levine L.S. 1987. Molecular and clinical advances in congenital adrenal hyperplasia. J Pediatr, 111: 1-17
88. Clark B.J., Soo S.C., Caron K.M. et al. 1995. Hormonal and development regulation of the steroidogenic acute regulatory protein. Mol Endocrinol, 9: 1346-1355.9
89. Simard J., Rheaume E., Sanchez R. et al 1993. Molecular basis of congenital adrenal hyperplasia due to 30 HSD deficiency Mol Endocrinol, 7 716-728
90. Sanchez R., Rheaume E., Laflamme N. et al. 1994 Detection and functional characterization of the novel missense mutation Y254D in type II 3β HSD gene of a female patient with non salt losing 3β HSD deficiency J Clin Endocrinol Metab, 78: 561-567
91. Barbieri R.L. 1992 Hyperandrogenism, new insights into etiology, diagnosis and therapy. Curr Opin Obstet Gynecol, 4: 372-379
92. Azziz R., Bradley E.L., Potter D. et al. 1994 3β hydroxy steroid dehydrogenase deficiency in hyperandrogenism Am J Obstet Gynecol, 168: 889-895
93. Araki S., Chikasawa K., Sekiguchi I. et al. 1987 Arrest of follicular development in a patient with 17α hydroxylase deficiency folliculogenesis in association with a lack of estrogen synthesis in the ovaries Fertil Steril, 47: 169-172
94. Rabinovici J., Blakstein J., Goldman B. et al. 1989 In vitro fertilization and primary embryonic cleavage are possible in 17a hydroxylase deficiency despite extremely low intrafollicular 17β œstradiol. J Clin Endocrinol Metab, 68: 693-697
95. Pellicer A., Miro F., Sampaio M. et al. 1991. In vitro fertilization as a diagnosis and therapeutic tool in a patient with partial 17-20 desmolase deficiency. Fertil Steril, 55: 970-975
96. Schoot B.C., Harlin J., Shoham Z. et al. 1994 Human recombinant follicle stimulating hormone and ovarian response in gonadotropin deficient women Hum Reprod, 9. 1237-1242
97. Simpson E.R., Mahendroo M.S., Means G.D. et al. 1994 Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev, 15: 342-355
98. Mango D., Montemurro A., Scripa P. et al. 1978 Four cases of pregnancy with low estrogen production due to placenta enzymatic deficiency Eur J Obstet Gynæcol Reprod Biol, 8: 65-67
99. Harada N., Ogawa H., Shozu M. et al. 1992. Genetic studies to characterize the origin of the mutation in placenta aromatase deficiency. Am J Hum Genet, 51: 666-672
100. Harada N., Ogawa H., Shozu M. et al. 1992. Biochemical and molecular genetic analysis on placenta aromatase (P450 arom) deficiency. J Biol Chem, 267: 4781-4785
101. Conte F.A., Grumbach M.M., Ito Y. et al. 1994. A syndrome of pseudohermaphroditism, hypergonadotropic hypogonadisin, and multicystic ovaries associated with missense mutations in the gene encoding aromatase. J Clin Endocrinol Metab, 78 1287-1292
102. Morishima A., Grumbach M.M., Simpson E.R. et al. 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens J Clin Endocrinol Metab, 80 3689-3698
103. Smith E.P., Boyd J., Franck G.R. et al. 1994 Estrogen resistance caused by a mutation in the estrogen receptor gene in a man N Engl J Med, 331 1056-1061
104. Ito Y., Fisher C.R., Conte F. et al. 1993. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA, 90 11673-11677
105. Bulun S.E. 1996. Aromatase deficiency in women and men would you have predicted the phenotypes? J Clin Endocrinol Metab, 81: 867-871
106. Geissler W.M., Davis D.I., Wu L. et al. 1994. Male pseudohermaphroditism caused by mutations of testicular 17β hydroxysteroid dehydrogenase 3. Nat Genet, 7: 34-39
107. Strauss J.F., Miller W.L. Molecular basis of ovarian steroid synthesis. In Hillier S.G. (ed), Ovarian Endocrinology 1991 Blackwell Scientific Publications, Oxford p 25-72
108. Andersson S., Geissler W.N., Wu L., Davis D.L., Grumbach M.M. et al. 1996. Molecular genetics and pathophysiology of 17β hydroxysteroid deshydrogenase 3 deficiency. J Clin Endocrinol Metab; 81: 130-136
109. Russel D.W., Berman D.M., Bryant J.T. et al. 1994. The molecular genetics of steroid 5 α reductase Recent Prog Horm Res, 49. 275-284
110. Andersson S., Berman D.M., Jenkins E.P. et al. 1991. Deletion of steroid 5 α reductase 2 in gene in male pseudohermaphroditism. Nature, 354: 159-161
111. Wilson J.D., Griffin J.E., Russel D.W. 1993. Teroid 5 α reductase 2 deficiency. Endocr Rev, 14: 577-593
112. Miller W.L. 1994. Genetics, diagnosis, and management of 21 hydroxylase deficiency J Clin Endocrinol Metab, 78 241-246
113. White P.C., New M.I. 1992. Genetic basis of endocrine diseases, congenital adrenal hyperplasia due to 21 hydroxylase deficiency. J Clin Endocrinol Metab, 74: 6-11
114. White P.C. 1989 Analysis of mutations causing steroid 21 hydroxylase deficiency. Endocr Res, 15: 239-256
115. Strachan P.C. 1990. Molecular pathology of congenital adrenal hyperplasia. Clin Endocrinol, 32 373-393
116. Mornet E., Crete P., Kutten F. et al.1991 Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of 21 hydroxylase deficiency Am J Hum Genet, 48. 79-88
117. Speiser P.W., Dupont J., Zhu D. et al. 1992 Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21 hydroxylase deficiency J Clin Invest, 90: 584-595
118. Mulaikal R.M., Migeon C.J., Rock J.A. 1987 Fertility rates in female patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. N Engl J Med, 316 178-182
119. Feldman S., Billaud L., Thabalard J.C. et al. 1992 Fertility in women with late onset adrenal hyperplasia due to 21 hydroxylase deficiency. J Clin Endocrinol Metab, 74 635-639
120. White P.C., Curnow K.M. Pascoe L 1994 Disorders of steroid 11β -hydroxylase isoenzymes Endocr Rev, 15 421-439
121. Curnow K.M., Slutsker L., Vitek J. et al. 1993. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci USA, 90: 4552-1556
122. Veldhuis J.D., Melby J.C. 1981. Isolated aldosterone deficiency in man: acquired and inborn errors in the biosynthesis or action of aldosterone. Endocr Rev; 2 : 495-517
123. New M.I., Oberfield S.E., Levine L.S., Dupont B., Pollack M.S., Gill J.R. 1980. Demonstration of autosomal dominant transmission and the absence of HLA linkage in dexamethasone suppressible hyperaldosteronism. Lancet; 1: 550-551
124. French F.S., Lubahn D.B., Brown T.R. et al. 1990. Molecular basis of androgen insensivity Recent Prog Horm Res 1990, 46 1-38
125. Brinkmann A.O., Jenster G., Kuiper G.G. et al. Structure and function of the human androgen receptor. In Nieschlag E., Habenicht U.F., Nieschlag S. (eds), Spermatogenesis - fertilization - Contraception. Springer-Verlag, Berlin, pp 97-122
126. Brown T.R., Scherer P.A., Chang YT et al. 1993. Molecular genetics of human androgen insensivity Eur J Pediatr, 152 (suppl 2), S62-S69
127. Janne O.A., Palvimo J.J., Kallio P. et al. 1993. Androgen receptor and mechanism of androgen action. Ann Med, 25: 83-89
128. McPhaul M.J., Marcelli M., Zoppi S. et al. 1993. The spectrum of mutations in the androgen receptor gene that causes androgen resistance J Clin Endocrinol Metab, 76: 17-23
129. Pinsky L., Trifiro M., Beitel L. et al. Molecular genetics of androgen insensitivity syndromes in humans, in Pinsky L. (ed), Molecular genetics of sex determination. Academic Press, New York, pp 341-365
130. Sultan C., Lumbroso S., Poujol N. et al. 1993. Mutations of androgen receptor gene in androgen insensitivity syndromes J Steroid Biochem Mol Biol, 46: 519-530
131. Prior L., Bordet S., Trifiro M.A. et al. 1992. Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes Am J Hum Genet, 51: 143-155
132. Griffin J.E., Wilson J.D. 1989. The androgen resistance syndromes in humans 5 α reductase deficiency, testicular feminization and related disorders. In Scriver CR, Beaudet AL, Sly WS, and Valle D (eds), The metabolic basis of inherited disease. Williams and Wilkins, New York, pp 1919-1944
133. Amato A.A., Prior T.W., Barohn R.J. et al. 1993 Kennedy's disease, a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology, 43: 791-794
134. Lubahn D.B., Moyer J.S., Golding T.S. et al. 1993. Alterations of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene Proc Natl Acad Sci USA, 90, 11162-11166
135. Korach K.S, Couse J.F, Curtis S.W. et al. 1996. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes Rec Progr Horm Res, 51 159-188
136. Lehrer S., Sanchez M., Song H.K. et al. 1990 Estrogen receptor B-polymorphism and spontaneous abortion in women with breast cancer Lancet, 335. 622-624
137. Lehrer S., Rabin J., Kalir T. et al. 1993 Estrogen receptor variant and hypertension in women Hypertension, 21: 439-441
138. Josso N., Cate R.L., Picard J Y. et al. 1993 Anti-Mullerian hormone: the Jost factor Recent Prog Horm Res, 48 1-59
139. Lee M.M., Donahoe P.K. 1993 Mullerian inhibiting substance a gonadal hormone with multiple functions Endocr Rev 14: 152-164
140. Diclemente N., Wilson C., Faure E. et al. 1994 Cloning, expression, and alternative splicing of the receptor for anti-Mullerian. Hormone Mol Endocrinol, 8 1006-1020
141. Grootegoed J.A., Baarends W.M., Themmen A.P.N. 1994 Welcome to the family the anti-Mullerian hormone receptor Mol Cell Endocrinol, 100 29-34
142. Imbeaud S., Carré-Eusèbe, Rey et al. 1994. Molecular genetics of the persistent Mullerian duct syndrome, a study of 19 families. Hum Mol Genet, 3: 125-131
143. Imbeaud S., Faure E., Lamarre I. et al. 1995 Insensivity to anti-Mullerian hormone due to a mutation in the human anti-Mullerian hormone receptor gene Nature Genetics, 11: 382-388
144. Imbeaud S., Belville C., Messika-Zeitoun L. et al. 1996. A 27 base-pair deletion of the anti-Mullerian type II receptor gene is the most common cause of persistent Mullerian duct syndrome. Hum Mol Genet, 5 1269-1279
145. Kwok C., Weller P.A., Guioli S. et al. 1995. Mutations in SOX9, the gene responsible for campomelic dysplasia and autosomal sex reversal. Am J Hum Genet, 57: 1028-1036
146. Südbeck P., Lienhard Smitz M., Bauerle P.A. et al. 1996. Sex reversal by loss of the C terminal transactivation domain of human Sox 9 Nature Genet, 13: 230-232
147. Morais da Silva S., Hacker A., Harley V. et al. 1996. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nature Genet, 14: 62-68
148. Kaufman F.R., Xu Y.K., Ng W.G. 1989. Gonadal function and ovarian galactose metabolism in clinical galactosemia. Acta Endocrinol, 120: 129-133
149. Thakker R.V. 1993. The molecular genetics of the multiple endocrine neoplasm syndromes. Clin Endocrinol, 38, 1-14
150. Guidice L.C. 1992. Insulin like growth factors and ovarian follicular development. Endocr Rev, 13: 641-669
151. Katz E., Ricciarelli E., Adashi E.Y. 1993. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril, 59. 8-34
152. Rosenfeld R.G., Rosenbloom A.L., Guevara-Aguirre J. 1994. Growth hormone insensitivity due to primary GH receptor deficiency. Endocr Rev, 15. 369-390
153. Dor J., Ben-Shlomo I., Lunenfeld B. et al. 1992. Insulin like growth factor may not be essential for ovarian follicular development: evidence from IGF1 deficiency. J Clin Endocrinol Metab, 74: 539-542
154. Woods K., Camacho-Hübner C., Savage M.O., Clark A.J.L 1996. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growih factor I gene N Engl J Med 1996, 315. 1365-1365
155. Tamura T., Tohma Tohta T. et al. 1993 Ring chromosome 15 involving deletion of the Insulin like growth factor 1 receptor gene in a patient with features of silver - russel syndrome. Clin Dysmorphol, 2: 106-113
156. Yen S.S. 1980. The polycystic ovary syndrome Clin Endocrinol, 12: 177-207
157. Francks S. 1989. Polycystic ovary syndrome a changing perspective. Clin Endocrinol, 31: 87-120
158. Fauser B.C.J.M. Classification of chronic hyperandrogenic annovulation In Coelingh Bennink H J.T , Vemer H.M , Van Keep P.A. (eds). Chronic hyperandrogenic anovulation Parthenon Publishing Group, Carnforth, UK, pp13-17
159. Erikson G.F., Hsueh A.J.W., Quigley M.E. et al. 1979. Functionnal studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab, 49: 514-519
160. Pache T.D., Hop W.C., De Jong F.H. et al. 1992 17β œstradiol, androstenedione and inhibin levels in fluid from individual follicles of normal or polycystic ovaries, and in ovaries from androgen treated female to male transsexuals Clin Endocrinol, 36: 565-571
161. Fauser B.C.J.M., Pache T.D.1994 Polycystic ovary syndrome normal and abnormal follicle development. In Schats R. and Schoemaker J (eds) Ovarian endocrinopathies Parthenon Publishing, New York, pp 117-127
162. Givens J.R. 1988 Familial polycystic ovarian disease. Endocrinol Metab Clin North Am. 17 771-783
163. Hague WM, Adams J, Reeders ST et al. 1988 Familial polycystic ovaries a genetic disease? Clin Endocrinol 29 593-605
164. Simpson E.R., McAllister J.M., Lauber M. et al. 1992. Regulation of expression of genes that encodes steroidogenic enzymes in the ovary. In Dunaif A., Givens J R., Hasetine F.P (eds). Polycystic ovary syndrome, Blackwell scientific publications. Boston, pp 71-77
165. Simpson J.L. 1992. Elucidating the genetics of polycystic ovary syndrome. In Dunaif A., Givens J.R., Hasetine F.P. (eds) Polycystic ovary syndrome, Blackwell scientific publications. Boston, pp 59-69
166. Hague W.M., Adams J., Algar V. et al. 1990 HLA associations, in patients with polycystic ovaries and in patients with congenital adrenal hyperplasia caused by 21 hydroxylase deficiency Clin Endocrinol, 32: 407-415
167. Ober C., Weil S., Steck T. et al. 1992 Increased risk for polycystic ovary syndrome associated with human leukocyte antigen DQA1 0501. Am J Obstet Gynecol, 167: 1803-1806
168. McKenna T.J. 1988. Pathogenesis and treatment of polycystic ovary syndrome. N Engl J Med, 318: 558-562
169. Lobo R.A., Goebelsmann U. 1980. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21 hydroxylase deficiency mimicking polycystic ovarian disease. Am J Obstet Gynecol, 138: 720-726
170. Chrousos G.P., Loriaux D.L., Mann D.L. et al. 1982. Late onset 21 hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Intern Med, 96: 143-148
171. Dewailly D., VanTyghem-Haudiquet M.C., Sainsard C. et al. 1986. Clinical and biological phenotypes in late onset 21 hydroxylase deficiency. J Clin Endocrinol Metab, 63. 418-423
172. Speiser P.W., Dupont J., Zhu D. et al. 1992. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21 hydroxylase deficiency. J Clin Invest, 90: 584-595
173. - Azziz R., Dewailly D., Owerbach D. 1994. Non classical adrenal hyperplasia, current concepts J Clin Endocrinol Metab, 78: 810-815
174. Kutten F., Couillin P., Girard F. et al 1985 Late onset adrenal hyperplasia in hirsutism. N Engl J Med, 313: 224-231
175. Cathelineau G., Brerault J.L., Fiet J. et al. 1980. Adrenocortical 11β (hydroxylation defect in adult women with postmenarcheal onset of symptoms J Clin Endocrinol Metab, 51: 287-293
176. Azziz R., Boots L.R., Bradley E. et al. 1991. 11β hydroxylase defect in hyperandrogenism Fertil Steril, 55. 733-741
177. Azziz R., Bradley E.L., Potter D. et al. 1994 3β hydroxysteroid dehydrogenase deficiency in hyperandrogenism. Am J Obstet Gynecol, 168: 889-895
178. Rosenfield R.L., Barnes R.B., Cara J.F. et al. 1990. Deregulation of cytochrome P450 17α as the cause of polycystic ovarian syndrome. Fertil Steril, 53: 785-791
179. Barnes R.B. 1991 Polycystic ovary syndrome and ovarian steroidogenesis Semin Reprod Endocrinol, 9: 360-366
180. Pang S., Softness B., Sweeney W.J. et al. 1987. Hirsutism, polycystic ovarian disease and ovarian 17 ketosteroid reductase deficiency N Engl J Med, 316: 1295-1301
181. Carey A.H., Waterworth D., Patel K. et al. 1994 Polycystic ovaries and premature male baldness are associated with one allele of ihe steroid metabolism gene CYP17 Hum Mol Genet, 3: 1873-1876
182. Toscano V., Balducci R., Bianchi P. et al. 1990. Ovarian 17 ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease. J Clin Endocrinol Metab, 71. 288-292
183. Taylor S.I., Cama A., Accili D. et al. 1991. Genetic basis of endocrine disease I Molecular genetics of insulin resistant diabetes mellitus. J Clin Endocrinol Metab, 73: 1158-1163
184. Cama A., Luz Sierra M., Ottini L. et al. 1991. A mutation in the tyrosine kinase domain on the insulin receptor associated with insulin resistance in an obese woman J Clin Endocrinol Metab, 73: 894-901
185. Takenani Y. 1990. Pathophysiology of polycystic ovary syndrome. Overview Horm Res, 33 (suppl 2), 3-4
186. Conway G.S., Jacobs H.S. 1993. Clinical implications of hyperinsulmaemia in women. Clin Endocrinol, 3: 623-632
187. Conway G.S., Avey C., Rumsby G. 1994. The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinemia and polycystic ovary syndrome. Hum Reprod, 9 1681-1683
188. Nestler J.E., Strauss J.F. 1991 Insulin as an effector of human ovarian and adrenal steroid metabolism Endocrinol Metab Clin North Am, 20: 807-823
189. Ciaraldi T.P., El Roeiy A., Madar Z. et al. 1992 Cellular mechanisms of insulin resistance in polycystic ovarian syndrome J Clin Endocrinol Metab, 75: 577-583
190. Poretski L 1991 On the paradox of insulin induced hyperandrogenism in insulin resistant states. Endocr Rev, 12. 3-13
191. Tan S.L., Hague W.M., Becker F. et al. 1986. Autoimmune premature ovarian failure with polyendocrinopathy and spontaneous recovery of ovarian follicular activity. Fertil Steril, 45. 421-424
192. Wilkin T.J. 1990 Receptor autoimmunity in endocrine disorders. N Engl J Med, 323: 1318-1324
193. Uibo R., Aavik E., Peterson P. et al. 1994. Antibodies to cytochrome P450 enzymes P45scc, P450cl7, P450c21 in autoimmune polyglandular disease type 1 and 11 and in isolated Addison's disease. J Clin Endocrinol Metab, 78: 323-328
194. Chen S., Sawicka J., Betterle C. et al 1996. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome. Addison's disease, and premature ovarian failure J Clin Endocrinol Metab; 81: 1871-1876